Sumitomo Mitsui Trust Group
ONC icon

Sumitomo Mitsui Trust Group’s BeOne Medicines Ltd ONC Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,529
Closed -$3.86M – 1202
2022
Q4 		$3.86M Sell
17,529
-101,851
-85% -$18.7M ﹤0.01% 867
2022
Q3 		$16.1M Buy
119,380
+1,853
+2% +$318K 0.01% 738
2022
Q2 		$19M Buy
117,527
+8,182
+7% +$1.28M 0.01% 726
2022
Q1 		$20.6M Buy
109,345
+3,012
+3% +$640K 0.01% 726
2021
Q4 		$28.8M Sell
106,333
-4,293
-4% -$1.45M 0.02% 663
2021
Q3 		$40.2M Sell
110,626
-1,263
-1% -$413K 0.03% 598
2021
Q2 		$38.4M Sell
111,889
-7,893
-7% -$2.61M 0.02% 615
2021
Q1 		$41.7M Buy
119,782
+333
+0.3% +$110K 0.03% 591
2020
Q4 		$30.9M Sell
119,449
-132,258
-53% -$36.4M 0.02% 644
2020
Q3 		$72.1M Buy
251,707
+79,700
+46% +$18.7M 0.05% 388
2020
Q2 		$32.4M Sell
172,007
-2,006
-1% -$327K 0.02% 602
2020
Q1 		$21.4M Buy
174,013
+13,895
+9% +$2.17M 0.02% 619
2019
Q4 		$26.5M Buy
160,118
+4,048
+3% +$673K 0.02% 635
2019
Q3 		$19.1M Buy
156,070
+19,714
+14% +$2.62M 0.02% 655
2019
Q2 		$16.9M Sell
136,356
-753
-0.5% -$95.6K 0.02% 682
2019
Q1 		$18.1M Sell
137,109
-2,246
-2% -$303K 0.02% 648
2018
Q4 		$19.1M Buy
+139,355
New +$18.5M 0.02% 608

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group's ONC Position: Q1 2023 in Review

Sumitomo Mitsui Trust Group sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 17,529 shares — an estimated $3.86M sold.

Sumitomo Mitsui Trust Group first reported a position in ONC in Q4 2018 and held it in 17 quarters. The position peaked at $72.1M in Q3 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Sumitomo Mitsui Trust Group reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 17,529 BeOne Medicines Ltd shares in Q1 2023, an estimated $3.86M.
  • Sumitomo Mitsui Trust Group first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 17 quarters.
  • Sumitomo Mitsui Trust Group's BeOne Medicines Ltd position peaked at $72.1M in Q3 2020.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2023, filed 27 Apr 2023.